Financhill
Back

Blueprint Medicines Stock Predictions

Blueprint Medicines Stock Forecast

  • Over the next 52 weeks, Blueprint Medicines has on average historically risen by 24.1% based on the past 10 years of stock performance.
  • Blueprint Medicines has risen higher in 7 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 70%
  • Is Blueprint Medicines Stock Undervalued?
    The current Blueprint Medicines [BPMC] share price is $128.12. The Score for BPMC is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • BPMC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Blueprint Medicines Stock Go Up Next Year?

  • Over the next 52 weeks, Blueprint Medicines has on average historically risen by 24.1% based on the past 10 years of stock performance.

Blueprint Medicines Stock Rating

Buy
52
Blueprint Medicines (BPMC) is a Buy

Is Blueprint Medicines overpriced?

  • Blueprint Medicines has risen higher in 7 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 70%

Blueprint Medicines Stock Price History

Is BPMC stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
blueprintmedicines.com

52-Week Data

52-Week High:
128.34
52-Week Low:
73.04

Prediction Charts

Market Cap:
8.3B
Price in USD:
128.12
Volume:
3.5M
Beta:
0.96

Technical Analysis

SMA50:
102.34
SMA100:
99.31
SMA200:
95.74
52-Wk Change:
20.06%

Stock Predictions

  • Is Blueprint Medicines stock public?
    Yes, Blueprint Medicines is a publicly traded company.
  • What is the Blueprint Medicines stock quote today?
    The Blueprint Medicines stock price is 128.12 USD today.
  • How to buy Blueprint Medicines stock online?
    You can buy Blueprint Medicines shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-30 103.17 101.35 103.17 100.57
Jun-2 128.01 127.79 128.15 127.43
Jun-3 127.85 127.60 127.97 127.45
Jun-4 127.70 128.10 128.14 127.60
Jun-5 128.10 127.90 128.24 127.83
Jun-6 128.07 127.85 128.07 127.77
Jun-9 127.98 127.97 127.98 127.65
Jun-10 127.95 127.97 128.10 127.75
Jun-11 127.97 127.95 128.34 127.83
Jun-12 128.03 128.21 128.26 127.94
Jun-13 128.18 127.96 128.27 127.95
Jun-16 128.05 128.25 128.30 127.86
Jun-17 128.14 128.23 128.33 128.03
Jun-18 128.29 128.12 128.32 128.02

Blueprint Medicines Earnings

Blueprint Medicines Earnings Report: Per Share Blueprint Medicines Earnings Q1 Q2 Q3 and Q4 last year and next year.

Blueprint Medicines Forecast Revenue Growth

Blueprint Medicines Stock Analysis: Historical quarterly revenues per share for Blueprint Medicines and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.67 per share, an increase next quarter of $0.33 per share, an increase this year of $0.60 per share, and an increase next year of $1.50 per share.

* Blueprint Medicines stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.